Androgen receptor inhibition extends PARP inhibitor activity in prostate cancer models beyond BRCA mutations and defects in homologous recombination repair.
雄激素受体抑制作用将 PARP 抑制剂在前列腺癌模型中的活性扩展到 BRCA 突变和同源重组修复缺陷之外。
期刊:NAR Cancer
影响因子:3.2
doi:10.1093/narcan/zcaf035
Illuzzi Giuditta, Galbiati Alessandro, Staniszewska Anna D, Hanson Robert, Michaloglou Chrysiis, Cooke Sophie L, UznaÅska Karolina, BiaÅecka Maja, Solarczyk Kamil, Dev Harveer S, Massie Charlie E, Albertella Mark R, Leo Elisabetta, Forment Josep V, O'Connor Mark J